Your browser doesn't support javascript.
loading
Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal.
Tamborero, David; Dienstmann, Rodrigo; Rachid, Maan Haj; Boekel, Jorrit; Baird, Richard; Braña, Irene; De Petris, Luigi; Yachnin, Jeffrey; Massard, Christophe; Opdam, Frans L; Schlenk, Richard; Vernieri, Claudio; Garralda, Elena; Masucci, Michele; Villalobos, Xenia; Chavarria, Elena; Calvo, Fabien; Fröhling, Stefan; Eggermont, Alexander; Apolone, Giovanni; Voest, Emile E; Caldas, Carlos; Tabernero, Josep; Ernberg, Ingemar; Rodon, Jordi; Lehtiö, Janne.
Afiliación
  • Tamborero D; Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden. david.tamborero@ki.se.
  • Dienstmann R; Medical Oncology-Oncology Data Science (ODysSey) Group, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Rachid MH; Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
  • Boekel J; Department of Oncology and Pathology, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden.
  • Baird R; Cancer Research UK Cambridge Centre, Cambridge, UK.
  • Braña I; Medical Oncology Department, Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • De Petris L; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Yachnin J; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Massard C; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Opdam FL; Theme Cancer, Karolinska University Hospital, Stockholm, Sweden.
  • Schlenk R; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Vernieri C; Department of Medical Oncology and Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Garralda E; NCT Trial Center, German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany.
  • Masucci M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Villalobos X; IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy.
  • Chavarria E; Medical Oncology Department, Vall d'Hebron Institute of Oncology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Calvo F; Research Coordination Area, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Fröhling S; Research Coordination Area, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain.
  • Apolone G; Gustave Roussy Cancer Campus Grand Paris, Villejuif, France Cancer Core Europe, Villejuif, France.
  • Voest EE; Division of Translational Medical Oncology, National Center for Tumor Diseases Heidelberg and German Cancer Research Center, Heidelberg, Germany.
  • Caldas C; German Cancer Consortium, Heidelberg, Germany.
  • Tabernero J; Scientific Directorate, Princess Máxima Center, Utrecht, the Netherlands.
  • Ernberg I; Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Rodon J; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Lehtiö J; Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Nat Med ; 26(7): 992-994, 2020 07.
Article en En | MEDLINE | ID: mdl-32632195

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Medicina de Precisión / Terapia Molecular Dirigida / Oncología Médica / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Medicina de Precisión / Terapia Molecular Dirigida / Oncología Médica / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Nat Med Asunto de la revista: BIOLOGIA MOLECULAR / MEDICINA Año: 2020 Tipo del documento: Article País de afiliación: Suecia